Related references
Note: Only part of the references are listed.Hypoxia-Inducible Factor-2α Activation Promotes Colorectal Cancer Progression by Dysregulating Iron Homeostasis
Xiang Xue et al.
CANCER RESEARCH (2012)
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dianren Xia et al.
NATURE MEDICINE (2012)
Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis
Y. Sasaki et al.
ONCOGENE (2012)
COX-2 Inhibitors and Cardiovascular Risk
Christopher P. Cannon et al.
SCIENCE (2012)
The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
A. Cesario et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Identification and development of mPGES-1 inhibitors: where we are at?
Hui-Hua Chang et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Hypoxia-Inducible Factor-2α Mediates the Adaptive Increase of Intestinal Ferroportin During Iron Deficiency in Mice
Matthew Taylor et al.
GASTROENTEROLOGY (2011)
Molecular Docking and Competitive Binding Study Discovered Different Binding Modes of Microsomal Prostaglandin E Synthase-1 Inhibitors
Shan He et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Mechanisms of Disease: Hypoxia and Inflammation.
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis
James J. Lee et al.
CARCINOGENESIS (2010)
Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors
Holly K. Koblish et al.
MOLECULAR CANCER THERAPEUTICS (2010)
HIF-1 and HIF-2 transcription factors - Similar but not identical
Agnieszka Loboda et al.
MOLECULES AND CELLS (2010)
Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression
Mazin A. Al-Salihi et al.
CANCER LETTERS (2009)
Intestinal Hypoxia-inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
Yatrik M. Shah et al.
CELL METABOLISM (2009)
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition
Pinku Mukherjee et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis
Masako Nakanishi et al.
CANCER RESEARCH (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Hypoxia-inducible factor 1a is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes
C. Grimmer et al.
ARTHRITIS AND RHEUMATISM (2007)
HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity
John D. Gordan et al.
CANCER CELL (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Prostaglandin E synthase: A novel drug target for inflammation and cancer
M Murakami et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1 alpha in non-small cell lung cancer
I Csiki et al.
CANCER RESEARCH (2006)
COX-2: A molecular target for colorectal cancer prevention
JR Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis
D Kamei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor
VH Haase et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
